Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Expression vector
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
===Gene therapy=== {{main|Vectors in gene therapy}} [[Gene therapy]] is a promising treatment for a number of diseases where a "normal" gene carried by the vector is inserted into the genome, to replace an "abnormal" gene or supplement the expression of particular gene. Viral vectors are generally used but other nonviral methods of delivery are being developed. The treatment is still a risky option due to the viral vector used which can cause ill-effects, for example giving rise to [[insertional mutation]] that can result in cancer.<ref>{{cite web |url=http://www.ornl.gov/sci/techresources/Human_Genome/medicine/genetherapy.shtml |title=Gene therapy |work=Human Genome Project }}</ref><ref>{{cite news |url=https://www.theguardian.com/society/2003/oct/17/research.sciencenews |title=Doctors discover why gene therapy gave boys cancer |author=Ian Sample |work=Guardian |date=17 October 2003 }}</ref> However, there have been promising results.<ref>{{cite news |url=https://www.theguardian.com/science/2013/apr/30/gene-therapy-trials-heart-patients|title= Pioneering gene therapy trials offer hope for heart patients|author=Sarah Boseley |work=Guardian |date=30 April 2013 }}</ref><ref>{{Cite journal | last1 = Fischer | first1 = A. | last2 = Hacein-Bey-Abina | first2 = S. | last3 = Cavazzana-Calvo | first3 = M. | doi = 10.1038/ni0610-457 | title = 20 years of gene therapy for SCID | journal = Nature Immunology | volume = 11 | issue = 6 | pages = 457β460 | year = 2010 | pmid = 20485269| s2cid = 11300348 }}</ref>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)